Cellular uptake of multilayered capsules produced with natural and genetically engineered biomimetic macromolecules

Acta Biomater. 2014 Jun;10(6):2653-62. doi: 10.1016/j.actbio.2014.02.020. Epub 2014 Feb 21.

Abstract

Multilayered microcapsules of chitosan and biomimetic elastin-like recombinamers (ELRs) were prepared envisaging the intracellular delivery of active agents. Two ELRs containing either a bioactive RGD sequence or a scrambled non-functional RDG were used to construct two types of functionalized polymeric microcapsules, both of spherical shape ∼4μm in diameter. Cell viability studies with human mesenchymal stem cells (hMSCs) were performed using microcapsule/cell ratios between 5:1 and 100:1. After 3 and 72h of co-incubation, no signs of cytotoxicity were found, but cells incubated with RGD-functionalized microcapsules exhibited higher viability values than RDG cells. The internalization efficacy and bioavailability of encapsulated DQ-ovalbumin were assessed by monitoring the fluorescence changes in the cargo. The data show that surface functionalization did not significantly influence internalization by hMSCs, but the bioavailability of DQ-ovalbumin degraded faster when encapsulated within RGD-functionalized microcapsules. The microcapsules developed show promise for intracellular drug delivery with increased drug efficacy.

Keywords: Biomaterials; Cellular uptake; Layer-by-layer; Multilayer capsules.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomimetics*
  • Capsules*
  • Cells, Cultured
  • Genetic Engineering*
  • Humans
  • Mesenchymal Stem Cells / cytology

Substances

  • Capsules